Core Insights - Strawberry Fields REIT, Inc. (STRW) and National Health Investors (NHI) are being compared for their value to investors, with STRW currently showing a stronger potential for value investment [1][3]. Valuation Metrics - STRW has a forward P/E ratio of 8.01, significantly lower than NHI's forward P/E of 15.09, indicating STRW may be undervalued [5]. - The PEG ratio for STRW is 1.00, while NHI's PEG ratio is 4.28, suggesting STRW has a better balance between price and expected earnings growth [5]. - STRW's P/B ratio stands at 1.43 compared to NHI's 2.3, further supporting STRW's position as a more attractive value option [6]. Analyst Ratings - STRW holds a Zacks Rank of 1 (Strong Buy), while NHI has a Zacks Rank of 2 (Buy), indicating a more favorable earnings estimate revision trend for STRW [3]. - STRW's solid earnings outlook and superior valuation metrics contribute to its Value grade of A, whereas NHI has a Value grade of D [6].

National Health Investors (NHI) Q1 2025 Earnings Call May 06, 2025 10:00 AM ET Company Participants Dana Hambly - VP - Finance & IREric Mendelsohn - President, CEO & Board MemberKevin Pascoe - CIOJohn Spaid - CFORichard Anderson - Managing Director - Equity ResearchJuan Sanabria - Managing DirectorFarrell Granath - Equity Research AssociateOmotayo Okusanya - Managing Director Conference Call Participants Austin Wurschmidt - Senior Equity Research Analyst Operator Greetings. Welcome to National Health Invest ...

National Health Investors (NHI) Q1 2025 Earnings Call May 06, 2025 10:00 AM ET Speaker0 Greetings. Welcome to National Health Investors First Quarter twenty twenty five Earnings Webcast and Conference Call. At this time, all participants are in a listen only mode. A question and answer session will follow the formal presentation. Please note this conference is being recorded. I will now turn the conference over to your host, Dana Hambly, Vice President, Finance and Investor Relations. You may begin. Speaker ...

Financial Performance - Net income per diluted share increased from $0.71 in Q1 2024 to $0.74 in Q1 2025[8] - NAREIT FFO per diluted share increased from $1.10 in Q1 2024 to $1.14 in Q1 2025[8] - Funds Available for Distribution (FAD) increased by 9.9% from $50.975 million in Q1 2024 to $56.001 million in Q1 2025[8] - Lease revenue excluding straight-line, lease amortization, and escrow reimbursement revenue of $65.3 million increased 8.0% compared to Q1 2024[11] SHOP Performance - SHOP NOI increased by 4.9% to $3.1 million in Q1 2025 compared to the prior year period[11] - SHOP NOI margin was 22.1% in Q1 2025, a decrease of 10 bps compared to the prior year period[11] - Average SHOP occupancy increased by 390 bps year-over-year to 89.2% in Q1 2025[11] - The company continues to estimate 12%-15% NOI growth for SHOP in 2025[11, 21] Balance Sheet and Investments - Net Debt to Adjusted EBITDA was 4.1x, at the low end of the company's target range of 4.0x – 5.0x[11] - The company announced 2025 YTD investments totaling $174.9 million at an average initial yield of approximately 8.2%[11] - The company is evaluating a pipeline of investment opportunities valued at approximately $264 million[11]

A detailed schedule for the 2025 guidance range as well as additional assumptions is included in this press release. Results for the three months ended March 31, 2025 compared to the same period in the prior year were impacted by the following: Exhibit 99.1 Contact: John L. Spaid, Chief Financial Officer Phone: (615) 890-9100 NHI Announces First Quarter 2025 Results MURFREESBORO, Tenn. – (Monday, May 5, 2025) National Health Investors, Inc. (NYSE:NHI) announced today its results for the three months ended M ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) Commission File Number 001-10822 National Health Investors, Inc. (Exact name of registrant as specified in its charter) Maryland 62-1470956 (State or other jurisdiction of incorporation or Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth company. See definition of "large accelerated filer", "ac ...

Group 1 - The healthcare sector is highlighted as a promising long-term investment opportunity, encompassing a diverse range of companies including pharmaceuticals, drug distributors, insurers, and hospitals [2] - The focus on income-producing asset classes suggests a strategy aimed at sustainable portfolio income, diversification, and inflation hedging [1] Group 2 - The article emphasizes the importance of performing due diligence and drawing personal conclusions before making investment decisions [4][5] - It is noted that past performance does not guarantee future results, indicating a cautious approach to investment recommendations [5]

Financial Data and Key Metrics Changes - The company reported a cash rent increase of nearly 9% year over year, contributing to a 12.5% growth in NOI [8][10] - NAREIT FFO per diluted common share increased by 3.6% to $4.55 for the year and $1.24 for the fourth quarter [32] - Normalized FFO per diluted common share increased by 2.5% and 2.8% to $4.44 and $1.12, respectively [32] - FAD for the year and quarter increased by 8.7% and 10% to $204.2 million and $52.1 million, respectively [33] Business Line Data and Key Metrics Changes - Bickford's cash rental income grew approximately 17% [10] - Shop NOI increased by approximately 32%, driven by improved occupancy and margin improvement [10][29] - The discretionary senior housing portfolio had coverage of 1.7 times compared to 1.6 times in the previous period [27] Market Data and Key Metrics Changes - The company’s balance sheet leverage decreased to 4.1 times from 4.4 times in the previous quarter [9] - The shop portfolio occupancy improved by 620 basis points to 89.4% [29] - The company expects to see continued growth in the senior housing industry, which has strong tailwinds [13] Company Strategy and Development Direction - The company plans to transition select triple net senior housing assets to shop structures to enhance shareholder value [13] - The strategy includes increasing RevPAR to drive margin expansion, targeting 12% to 15% NOI growth for 2025 [14][46] - The company aims to strategically invest $225 million in new investments at an average yield of 8.1% for 2025 [45] Management's Comments on Operating Environment and Future Outlook - Management expressed optimism for 2025, expecting continued growth supported by rent step-ups and deferral repayments [12][16] - The company is positioned to capitalize on favorable industry fundamentals, despite recent interest rate pressures [17] - Management acknowledged the need to balance investments in existing operations with new market opportunities [127] Other Important Information - The company declared a dividend of $0.90 per share for shareholders of record on March 31, 2025 [43] - The company has approximately $327 million available on its revolver and $45 million in ATM capacity [41] Q&A Session Summary Question: Rent and interest income expectations for 2025 - Management expects rent and interest income to be closer to 55% for 2025 compared to 2024 [52] Question: Comments on Bickford's occupancy - Management noted that Bickford experienced some seasonal effects and price point adjustments impacting occupancy [78] Question: Clarification on acquisition guidance - Management explained that the guidance of $225 million reflects expected closings from LOIs, with confidence in achieving this number [82][84] Question: Future of the Discovery portfolio - Management indicated that they are evaluating options for the Discovery portfolio, including potential re-tenanting [96] Question: Dividend rationale - Management stated that maintaining the current dividend aligns with long-term growth objectives and market conditions [124]

National Health Investors Q4 2024 Supplemental TABLE OF CONTENTS COMPANY | COMPANY INFORMATION & LEADERSHIP | 02 | | --- | --- | | PORTFOLIO | | | PORTFOLIO OVERVIEW | 03 | | REAL ESTATE INVESTMENTS | 04 | | SENIOR HOUSING OPERATING PORTFOLIO | 05 | | OPERATING PARTNERS | 06 | | EBITDARM LEASE COVERAGE & OCCUPANCY | 07 | | PURCHASE OPTIONS & LEASE MATURITIES | 08 | | INVESTMENTS | | | INVESTMENT RATIONALE | 09 | | RECENT INVESTMENTS | 10 | | CAPITALIZATION | | | CAPITALIZATION OVERVIEW | 11 | | CAPITAL STRU ...

Core Insights - National Health Investors (NHI) reported revenue of $85.75 million for the quarter ended December 2024, marking a year-over-year increase of 7.9% and exceeding the Zacks Consensus Estimate by 2.52% [1] - The earnings per share (EPS) for the same period was $1.13, compared to $0.74 a year ago, with an EPS surprise of 2.73% over the consensus estimate of $1.10 [1] Revenue Breakdown - Rental income was reported at $65.78 million, surpassing the two-analyst average estimate of $62.06 million, reflecting a year-over-year change of 8.3% [4] - Interest income and other revenues amounted to $5.97 million, exceeding the estimated $5.43 million, with a year-over-year increase of 3% [4] - Resident fees and services generated $14 million, above the average estimate of $13.88 million, representing a year-over-year change of 8.1% [4] Stock Performance - Over the past month, shares of National Health Investors returned -0.2%, compared to a -1.8% change in the Zacks S&P 500 composite [3] - The stock currently holds a Zacks Rank 3 (Hold), indicating potential performance in line with the broader market in the near term [3]